Description

SAMHSA is accepting applications for Improving Access to Overdose Treatment (OD Treatment Access) grants totaling up to $4.7 million over the next five years. The purpose is to award Federally Qualified Health Centers, Opioid Treatment Programs, or practitioners who have a waiver to prescribe buprenorphine to expand access to Food and Drug Administration approved drugs or devices for emergency treatment of known or suspected opioid overdose. SAMHSA expects to fund up to 5 grantees with up to $200,000 per year for up to five years.